Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Post-transplantation Cyclophosphamide for Haploidentical Transplant
NCT02412423Phase 4Completed
- Sponsor
- Peking University People's Hospital
- Start
- Mar 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cyclophosphamide in graft-versus-host disease (GVHD), sponsored by Peking University People's Hospital. Started Mar 2015; status: completed.
02
Drugs
cyclophosphamide
03
Conditions
graft-versus-host disease (GVHD)
Beyond the preview
Go deeper on NCT02412423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02412423.